tirzepatide phase 3 trial is finally here – what's the big deal? – GP Voice New Trial Results Position Mounjaro

The move will limit access for an estimated 20,000 Australians who have been buying compounded versions of the drug because they cant access the branded products due to a global shortage

The landscape of medical weight loss has shifted dramatically in recent years, largely driven by the success of GLP-1 receptor agonists like Ozempic and Wegovy

GIP (Glucose-dependent Insulinotropic Polypeptide) A hormone released from the gut after eating that enhances insulin secretion

Explore Hydrafacial Microneedling From $310 Collagen-boosting skin renewal that softens fine lines, scars, and texture, with an Exosomes add-on